Potent and selective CB2 receptor agonist (Ki = 12.8 nM; EC50 = 38.67 nM). Exhibits negligible affinity for the CB1 receptor (Ki >40,000 nM) and no activity at the GPR55. Suppresses neuroinflammation by reducing microglial activation in a multiple sclerosis mouse model. BBB permeable; anti-inflammatory and neuroprotective.

1949726-13-9

C22H31NO3

357.49

PM 226;PM226

DMSO:Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years